Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring

Haiyan Yu, Oliver Bock, Ardeshir Bayat, Mark W. Ferguson, Ulrich Mrowietz

    Research output: Contribution to journalArticlepeer-review


    Keloids are benign skin tumours occurring during wound healing in genetically predisposed patients. They are characterised by an abnormal deposition of extracellular matrix components, in particular collagen. There is evidence that transforming growth factor-beta (TGFβ) is involved in keloid formation. SMAD proteins play a crucial role in TGFβ signaling and in terminating the TGFβ signal by a negative feedback loop through SMAD6 and 7. It is unclear how TGFβ signalling is connected to the pathogenesis of keloids. Therefore, we investigated the expression of SMAD mRNA and proteins in keloids, in normal skin and in normal scars. Dermal fibroblasts were obtained from punch-biopsies of keloids, normal scars and normal skin. Cells were stimulated with TGFβ1 and the expression of SMAD2, 3, 4, 6 and 7 mRNA was analysed by real time RT-PCR. Protein expression was determined by Western blot analysis. Our data demonstrate a decreased mRNA expression of the inhibitory SMAD6 and 7 in keloid fibroblasts as compared to normal scar (p
    Original languageEnglish
    Pages (from-to)221-229
    Number of pages8
    JournalJournal of Plastic, Reconstructive and Aesthetic Surgery
    Issue number3
    Publication statusPublished - Mar 2006


    • Keloids
    • SMAD
    • TGFβ
    • TGFβ signalling


    Dive into the research topics of 'Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring'. Together they form a unique fingerprint.

    Cite this